Search

everythinglearnresearchcommunity

for

Search:↓

New isatin-gallate hybrids show promise as antioxidants, cancer treatments, and coronavirus inhibitors.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

DA-9401 helps protect rat testis from finasteride damage.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Blocking JAK-STAT signaling can lead to hair growth.

Integrin-linked kinase is crucial for melanoblasts to properly colonize the skin.

Indinavir can cause hair loss and other skin problems.

Targeted cancer therapies often cause serious skin problems that need careful management.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Hedgehog pathway inhibitors could be effective in treating melanoma.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.